Publications by authors named "Tadasuke Chitose"

Claim this Profile
C
Coronary Artery Plaque Regression by a PCSK9 Antibody and Rosuvastatin in Double-heterozygous Familial Hypercholesterolemia with an LDL Receptor Mutation and a PCSK9 V4I Mutation.
Ryo Shirahama, Takamichi Ono, Suguru Nagamatsu, Daisuke Sueta, Seiji Takashio, Tadasuke Chitose

Intern Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response to rivaroxaban in a case of invaginated thrombus thought to have extended through a patent foramen ovale with an accompanying pulmonary embolism.
Tadasuke Chitose, Takuro Yamashita, Mitsutoshi Miura, Koshi Matsuyama

J Cardiol Cases· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
Tadasuke Chitose, Seigo Sugiyama, Kenji Sakamoto, Hideki Shimomura, Takuro Yamashita

Atherosclerosis· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravascular ultrasound morphology of culprit lesions and clinical demographics in patients with acute coronary syndrome in relation to low-density lipoprotein cholesterol levels at onset.
Naoko Takaoka, Kenichi Tsujita, Koichi Kaikita, Seiji Hokimoto, Kenshi Yamanaga, Tadasuke Chitose

Heart Vessels· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease.
Seiji Hokimoto, Tadasuke Chitose, Michio Mizobe, Tomonori Akasaka, Yuichiro Arima

Eur J Clin Pharmacol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes following coronary stenting in Japanese patients treated with and without proton pump inhibitor.
Tadasuke Chitose, Seiji Hokimoto, Shuichi Oshima, Koichi Nakao, Kazuteru Fujimoto

Circ J· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Premenopausal woman with acute myocardial infarction caused by spontaneous coronary artery dissection and potential association with coronary vasospasm.
Kenichi Tsujita, Takashi Miyazaki, Koichi Kaikita, Tadasuke Chitose, Naoko Takaoka

Cardiovasc Interv Ther· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status and prospects of antiplatelet therapy in percutaneous coronary intervention in Japan: focus on adenosine diphosphate receptor inhibitors.
Hisao Ogawa, Seiji Hokimoto, Koichi Kaikita, Koichiro Yamamoto, Tadasuke Chitose

J Cardiol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CYP2C19 polymorphism on residual platelet reactivity in patients with coronary heart disease during antiplatelet therapy.
Koichiro Yamamoto, Seiji Hokimoto, Tadasuke Chitose, Kazunori Morita, Takamichi Ono

J Cardiol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction.
Yoshinori Nakamura, Yoshihiro Yamada, Hideki Shimomura, Yasuhiro Nagayoshi, Kenichi Tsujita, Tadasuke Chitose

J Cardiol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis